Flamel Finds New Basulin Partner, Signs $165M Bristol-Myers Deal Aug. 28, 2003 By Brady Huggett No Comments Flamel Technologies SA again has partnered its recombinant human insulin product, Basulin; this time, signing a deal with Bristol-Myers Squibb Co. valued at up to $165 million. (BioWorld Today)Read More
Ambion, Cenix Make Available siRNAs For Humans, Mice, Rats Aug. 27, 2003 By Brady Huggett No Comments
Ambion, Cenix Make Available siRNAs For Humans, Mice, Rats Aug. 27, 2003 By Brady Huggett No Comments
IPOs On The Rise: Nitromed, Pharmion, Acusphere On File Aug. 22, 2003 By Brady Huggett and Aaron Lorenzo No Comments Three biotech companies recently have filed for initial public offerings in what appears to be a developing trend. (BioWorld Today)Read More
Nucleonics Licenses RNAi Rights From Wyeth For 5 Percent Stake Aug. 21, 2003 By Brady Huggett No Comments
Neurochem Files For U.S. IPO As Well As Follow-On In Canada Aug. 21, 2003 By Brady Huggett No Comments
Nucleonics Licenses RNAi Rights From Wyeth For 5 Percent Stake Aug. 21, 2003 By Brady Huggett No Comments
Neurochem Files For U.S. IPO As Well As Follow-On In Canada Aug. 21, 2003 By Brady Huggett No Comments
